Mavik and Bextra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mavik (trandolapril) and Bextra (valdecoxib). Common drug interactions include back pain among females and pain in extremity among males.

The phase IV clinical study analyzes what interactions people have when they take Mavik and Bextra. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Mavik?

Mavik has active ingredients of trandolapril. It is often used in high blood pressure. eHealthMe is studying from 3,145 Mavik users. Check the latest studies of Mavik.

What is Bextra?

Bextra has active ingredients of valdecoxib. It is often used in pain. eHealthMe is studying from 20,994 Bextra users. Check the latest studies of Bextra.



On Jul, 12, 2026

32 people who take Mavik and Bextra together, and have interactions are studied.

Mavik and Bextra drug interactions.

What are the common drug interactions of Mavik and Bextra, by gender? *:

female:

  1. Back pain
  2. Bone swelling
  3. Cataract (clouding of the lens inside the eye)
  4. Cellulitis (infection under the skin)
  5. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  6. Confusional state
  7. Emotional distress
  8. Fall
  9. Fibula fracture
  10. Foot fracture

male:

  1. Pain in extremity
  2. Acute respiratory failure
  3. Chills (felling of cold)
  4. Depression
  5. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  6. Drug dependence
  7. Drug ineffective
  8. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  9. Dyspnoea (difficult or laboured respiration)
  10. Emotional distress

What are the common drug interactions of Mavik and Bextra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Drug toxicity
  2. Lethargy (tiredness)
  3. Multiple drug overdose accidental
  4. Gastric ulcer haemorrhage (bleeding ulcer of stomach)
  5. Blood creatine phosphokinase increased
  6. Coma (state of unconsciousness lasting more than six hours)

60+:

  1. Erythema (redness of the skin)
  2. Abdominal pain
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Confusional state
  5. Emotional distress
  6. Fall
  7. Fibula fracture
  8. Foot fracture
  9. Hallucination (an experience involving the perception of something not present)
  10. Infection

What are the existing conditions these people have? *

  1. Paget's Disease (disorder that involves abnormal bone destruction and regrowth, which results in deformity): 10 people, 31.25%
  2. Osteoporosis (bones weak and more likely to break): 10 people, 31.25%
  3. Metastases To Bone (cancer spreads to bone): 10 people, 31.25%
  4. Breast Cancer: 10 people, 31.25%
  5. Spinal Osteoarthritis (joint cartilage loss in spine): 2 people, 6.25%
  6. Pain In Extremity: 2 people, 6.25%
  7. High Blood Cholesterol: 2 people, 6.25%
  8. Diabetes: 2 people, 6.25%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 6.25%
  10. Breast Cancer Metastatic: 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Mavik and Bextra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mavik and Bextra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mavik:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bextra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mavik and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bextra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on trandolapril and valdecoxib (the active ingredients of Mavik and Bextra, respectively), and Mavik and Bextra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: